HE4 is superior to CA125 in the detection of recurrent disease in high-risk endometrial cancer patients.
| Image |  |
|---|---|
| Description | scientific article published in February 2018 |
| Author/s |
author: Anneke J. Geurts-Moespot Antonius E van Herwaarden Fred Sweep |
| Publication date | February 1, 2018 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |